1621NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF¥ --

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF

1621

ETFOther

¥ -

Browse securities reports, semi-annual reports and earnings reports by fiscal period.

descriptionFinancial Summary

Figures come from the fund's annual securities report (EDINET). Operating revenue includes realised and unrealised gains on securities, so it can be negative — it is the fund's result for the period, not business revenue.

Net Assets

Fund size at each fiscal period end.

Effective Cost Ratio

Revenue Breakdown

Income (dividends and interest) versus gains and losses on securities. This shows what the fund actually earns from.

Financial Statements by Period

Japanese GAAP Unit: JPY

Item

Net assets

Principal

Retained earnings

Dividend income

Interest income

Securities gain/loss

Other income

Total operating revenue

Management fee

Trustee fee

Total operating expenses

Operating income

Net income

Distribution

descriptionFiling History

Earnings reports (TDnet) and securities reports (EDINET) by fiscal year. ETFs do not file quarterly reports.